Sponsor: Resolve Therapeutics, LLC
Investigational Product: RSLV-132
Title: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Impact of Intravenous RSLV-132 in Participants with Sjögren's Syndrome (SS) with Moderate to Severe Symptom Burden.
Rationale for Study: Sjögren's Syndrome (SS) is a chronic, often disabling, multi-system, autoimmune disease characterized by dryness or sicca symptoms involving ocular, oral and dermatologic organ systems. Additionally, it is associated with tiredness/fatigue, cognitive difficulties, and less often with involvement of other major organ systems including the musculoskeletal, renal, pulmonary, and hematologic.
Objectives:
To assess the efficacy of RSLV-132 on the cardinal symptom burden, and tiredness/fatigue, in female participants with SS.
Diabetic Foot Ulcer
Diabetic foot ulcers are chronic, non-healing open sores, usually on the bottom of the foot, caused by nerve damage (neuropathy), poor circulation, and pressure.
Treatment requires daily monitoring, offloading (reducing pressure), cleaning, and in severe cases, surgical intervention.
If you have been diagnosed with diabetes mellitus or have a foot ulcer, and are interested in participating, please contact us.
Crown Research is conducting a clinical study to evaluate an investigational rapid test designed to detect Influenza A and B in symptomatic patients.
Influenza is a highly contagious respiratory infection that can cause fever, cough, sore throat, body aches, fatigue, and other flu-like symptoms.
If you are experiencing flu-like symptoms and are interested in participating, please contact us.
